|
Systemic Sclerosis
Citations 151-160 of 242 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases
- P. M. Seferovic, A. D. Ristic, R. Maksimovic, D. S. Simeunovic, G. G. Ristic, G. Radovanovic, D. Seferovic, B. Maisch, and M. Matucci-Cerinic
Rheumatology 2006; 45: iv39-iv42.
[Abstract]
[Full Text]
- THERAPEUTIC STRATEGIES
The role of DMARDs in systemic sclerosis therapy
- N. Blank, R. Max, and H.-M. Lorenz
Rheumatology 2006; 45: iii42-iii44.
[Abstract]
[Full Text]
- THERAPEUTIC STRATEGIES
Vasoactive therapies in systemic sclerosis
- G. Riemekasten and C. Sunderkötter
Rheumatology 2006; 45: iii49-iii51.
[Abstract]
[Full Text]
- THERAPEUTIC STRATEGIES
Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
- C. Sunderkötter, A. Kuhn, N. Hunzelmann, and S. Beissert
Rheumatology 2006; 45: iii52-iii54.
[Abstract]
[Full Text]
- EDITORIALS
‘Quality of pain’ in systemic sclerosis
- P. E. Carreira
Rheumatology 2006; 45: 1185-1186.
[Extract]
[Full Text]
- REVIEW
Adult stem cells in the treatment of autoimmune diseases
- J. M. van Laar and A. Tyndall
Rheumatology 2006; 45: 1187-1193.
[Abstract]
[Full Text]
- CLINICAL
Impact of pain in health related quality of life of patients with systemic sclerosis
- C. Georges, O. Chassany, C. Toledano, L. Mouthon, K. Tiev, O. Meyer, D. Ilie, J. Rambeloarisoa, Z. Marjanovic, J. Cabane, D. Sereni, J. Pouchot, and D. Farge
Rheumatology 2006; 45: 1298-1302.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
‘Herbal medicine’ containing hidden prescription drugs
- J. K. Dowman, F. H. Khattak, S. Elliott, T. M. T. Sheehan, and K. A. Grindulis
Rheumatology 2006; 45: 1309-1312.
[Extract]
[Full Text]
- CLINICAL
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol
- G. Milio, E. Corrado, C. Genova, C. Amato, F. Raimondi, P. L. Almasio, and S. Novo
Rheumatology 2006; 45: 999-1004.
[Abstract]
[Full Text]
- BASIC SCIENCE
Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis
- F. Ogawa, K. Shimizu, E. Muroi, T. Hara, M. Hasegawa, K. Takehara, and S. Sato
Rheumatology 2006; 45: 815-818.
[Abstract]
[Full Text]
|
|
